Skip to main content
TipRanks
Go Ultimate75% OFF

Comprehensive Healthcare Systems Inc (CHS) AI Stock Analysis

3 Followers
TSE:CHS

Comprehensive Healthcare Systems Inc

(TSXV:CHS)

Select Model
Rating:39Underperform
Price Target:CAD 0.29â–¼(-8.44% Downside)
Action:reiterated
Date:11/19/26

The overall score is critically low, driven primarily by the company's insolvent balance sheet and massive cash burn, which pose an existential threat. The persistent downtrend in the stock price confirms the market's negative assessment of these fundamental risks. The negative P/E ratio further underscores the lack of earnings power, making the stock highly speculative and unsuitable for risk-averse investors.

Positive Factors
Revenue ReboundThe strong TTM revenue rebound indicates substantially improved demand or sales execution compared with the prior period. If maintained, this larger revenue base could improve operating leverage, support reinvestment, and provide a foundation for restoring profitability over the next several quarters.
Negative Factors
Deep UnprofitabilityThe very negative net margin shows that current revenue is not covering the company’s full cost structure. Worsening operating and EBITDA margins indicate weak operating leverage, making the revenue rebound less durable unless expense control or productivity improves materially.

Comprehensive Healthcare Systems Inc (CHS) vs. iShares MSCI Canada ETF (EWC)

-50%-25%0%25%50%75%100%TSE:CHS-36.00%EWC+11.69%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 9.57M
Dividend Yield
―
Average Volume (3M)
10.99K
Price to Earnings (P/E)
-1.5
Beta (1Y)
0.07
Revenue Growth
7.63%
EPS Growth
-106.03%
Country
Canada
Employees
47
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Comprehensive Healthcare Systems Inc Business Overview & Revenue Model

Company Description

Comprehensive Healthcare Systems Inc. focuses on designing and delivering custom-made administrative software for the healthcare sector. Their suite of services covers crucial aspects such as the issuance of membership cards, managing disease program...

Comprehensive Healthcare Systems Inc Financial Statement Overview

Summary

The company is in a state of severe financial distress. It is deeply unprofitable with a TTM net profit margin of -65.9%, technically insolvent with negative stockholders' equity of -$2.25M, and burning cash with a TTM free cash flow of -$2.69M. The overall financial health is critical, with viability in question without new capital.

Income Statement

18Very Negative

Balance Sheet

5Very Negative

Cash Flow

10Very Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Sep 2024Mar 2023Mar 2022
Income Statement
Total Revenue4.33M4.19M3.77M3.84M4.30M4.50M
Gross Profit2.34M2.37M2.06M1.15M1.40M1.37M
EBITDA-2.20M-1.10M121.99K-2.86M-4.95M-2.54M
Net Income-2.37M-2.18M-607.73K-3.58M-5.11M-4.93M
Balance Sheet
Total Assets2.59M925.61K652.20K964.56K2.11M4.11M
Cash, Cash Equivalents and Short-Term Investments1.41M39.88K7,66623.75K542.64K3.40M
Total Debt2.37M2.67M2.50M2.47M1.96M1.76M
Total Liabilities4.85M7.13M7.08M6.79M5.26M3.50M
Stockholders Equity-2.25M-6.20M-6.43M-5.82M-3.15M602.59K
Cash Flow
Free Cash Flow-2.69M-900.62K36.31K-1.23M-4.04M-3.28M
Operating Cash Flow-2.37M-723.57K366.80K-1.23M-3.97M-3.27M
Investing Cash Flow-92.47K-97.80K-628.01K0-68.41K215.14K
Financing Cash Flow3.79M854.22K245.07K852.45K1.04M4.39M

Comprehensive Healthcare Systems Inc Technical Analysis

Technical Analysis SentimentNegative
Last Price0.32

Price Trends

50DMA0.36Negative
100DMA0.40Negative
200DMA0.52Negative

Market Momentum

MACD-0.01Negative
RSI45.65Neutral
STOCH61.90Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CHS, the sentiment is Negative. The current price of 0.32 is below the 20-day moving average (MA) of 0.33, below the 50-day MA of 0.36, and below the 200-day MA of 0.52, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 45.65 is Neutral, neither overbought nor oversold. The STOCH value of 61.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CHS.

Comprehensive Healthcare Systems Inc Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:CHS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:VHITSE:VHI69NeutralCAD 403.31M36.494.03%―29.32%231.82%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:AIDRTSE:AIDR42NeutralCAD 38.48M-1.41-444.52%―415.06%-54.80%
TSE:CHSTSE:CHS39UnderperformCAD 9.28M-1.4764.52%―7.63%-106.03%
TSE:DMEDTSE:DMED39UnderperformCAD 2.63M-1.29739.84%――-28.35%
TSE:ADKTSE:ADK38UnderperformCAD 28.30M-5.699999.00%―-36.92%13.03%
TSE:UDOCTSE:UDOC38UnderperformCAD 3.45M-1.06355.56%―614.03%51.97%

* Healthcare Sector Average

Performance Comparison

0%100%200%TSE:CHSTSE:ADKTSE:VHITSE:AIDRTSE:UDOCTSE:DMEDDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:CHS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:CHSComprehensive Healthcare Systems Inc0.32-0.18-36.00%
TSE:ADKDiagnos Inc0.23-0.08-24.19%
TSE:VHIVitalhub Corp.6.36-3.01-32.12%
TSE:AIDRRocket Doctor Ai Inc0.38-0.42-52.50%
TSE:UDOCUnidoc Health Corp.0.04-0.11-74.19%
TSE:DMEDDiagnaMed Holdings Corp.0.02-0.04-69.23%

Comprehensive Healthcare Systems Inc Corporate Events

Business Operations and StrategyM&A TransactionsProduct-Related Announcements

Comprehensive Healthcare Systems Targets Growth at Major Employee Benefits Conference

Positive
Oct 22, 2026

Comprehensive Healthcare Systems Inc. will attend the International Foundation of Employee Benefit Plans 72nd Annual Employee Benefits Conference in New Orleans, a key gathering of more than 5,000 trustees, fund administrators and benefits profession...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 19, 2026